This metabolite provides a PDE selectivity profile similar to sildenafil and an in vitro potency for PDE5 somewhere around 50% on the mother or father drug. Plasma concentrations of the metabolite are close to 40% of People noticed for sildenafil, so the metabolite accounts for about 20% of sildenafil's pharmacologic outcomes.The impact on one of t